Search Results

Search

Ethics Talk: Equitable Allocation of SARS-CoV-2 Vaccine

Submitted by Audiey.Kao@ama… on

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Ruth Faden about how to fairly distribute any potential SARS-CoV-2 vaccine when supply is limited.

Click here to read the transcript.

Ruth Faden, PhD, MPH is a professor of biomedical ethics at the Johns Hopkins Berman Institute of Bioethics.

Video

 

Infectious Disease Professionalism

Audio

 

Conflict of Interest Disclosure
Dr Faden is principal investigator of a Wellcome Trust funded-project on COVID-19 and Nigeria. She is also a member of the Strategic Advisory Group of Experts on the Immunization Working Group on COVID-19 Vaccines in the World Health Organization.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Header Image image Issue Opioids and Public Health CME Off
Policy Forum
Aug 2021

How Does Cost-Effectiveness Analysis Inform Health Care Decisions?

David D. Kim, PhD and Anirban Basu, PhD
CEA has been increasingly used to inform public and private organizations’ reimbursement decisions, benefit designs, and price negotiations worldwide.
AMA J Ethics. 2021;23(8):E639-647. doi: 10.1001/amajethics.2021.639.
Policy Forum
Oct 2022

How Should We Better Manage Human and Planetary Health in a Next Pandemic?

Lisa Patel, MD, MESc and Katie E. Lichter, MD, MPH
Health care generates a lot of waste that enters landfills, oceans, and incinerators and adversely affects communities close to waste processing and disposal areas.
AMA J Ethics. 2022;24(10):E980-985. doi: 10.1001/amajethics.2022.980.